These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36644206)

  • 21. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical applicability of polygenic risk scores for LDL-cholesterol: considerations, current evidence and future perspectives.
    Cupido AJ; Tromp TR; Hovingh GK
    Curr Opin Lipidol; 2021 Apr; 32(2):112-116. PubMed ID: 33560669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study.
    Yamashita S; Masuda D; Harada-Shiba M; Arai H; Bujo H; Ishibashi S; Daida H; Koga N; Oikawa S
    J Atheroscler Thromb; 2022 May; 29(5):608-638. PubMed ID: 33980760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia.
    Khera AV; Won HH; Peloso GM; Lawson KS; Bartz TM; Deng X; van Leeuwen EM; Natarajan P; Emdin CA; Bick AG; Morrison AC; Brody JA; Gupta N; Nomura A; Kessler T; Duga S; Bis JC; van Duijn CM; Cupples LA; Psaty B; Rader DJ; Danesh J; Schunkert H; McPherson R; Farrall M; Watkins H; Lander E; Wilson JG; Correa A; Boerwinkle E; Merlini PA; Ardissino D; Saleheen D; Gabriel S; Kathiresan S
    J Am Coll Cardiol; 2016 Jun; 67(22):2578-89. PubMed ID: 27050191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland.
    Björnsson E; Thorgeirsson G; Helgadóttir A; Thorleifsson G; Sveinbjörnsson G; Kristmundsdóttir S; Jónsson H; Jónasdóttir A; Jónasdóttir Á; Sigurðsson Á; Guðnason T; Ólafsson Í; Sigurðsson EL; Sigurðardóttir Ó; Viðarsson B; Baldvinsson M; Bjarnason R; Danielsen R; Matthíasson SE; Thórarinsson BL; Grétarsdóttir S; Steinthórsdóttir V; Halldórsson BV; Andersen K; Arnar DO; Jónsdóttir I; Guðbjartsson DF; Hólm H; Thorsteinsdóttir U; Sulem P; Stefánsson K
    Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2616-2628. PubMed ID: 34407635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Past, Present, and Future of Familial Hypercholesterolemia Management.
    Rocha VZ; Santos RD
    Methodist Debakey Cardiovasc J; 2021; 17(4):28-35. PubMed ID: 34824679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic basis of hypercholesterolemia in adults.
    Saadatagah S; Jose M; Dikilitas O; Alhalabi L; Miller AA; Fan X; Olson JE; Kochan DC; Safarova M; Kullo IJ
    NPJ Genom Med; 2021 Apr; 6(1):28. PubMed ID: 33854068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.
    Tada H; Kawashiri MA; Nomura A; Teramoto R; Hosomichi K; Nohara A; Inazu A; Mabuchi H; Tajima A; Yamagishi M
    J Clin Lipidol; 2018; 12(6):1436-1444. PubMed ID: 30241732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polygenic Hypercholesterolemia and Cardiovascular Disease Risk.
    Sharifi M; Futema M; Nair D; Humphries SE
    Curr Cardiol Rep; 2019 Apr; 21(6):43. PubMed ID: 31011892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease.
    Pirazzi C; Håkansson L; Gustafsson C; Omerovic E; Wiklund O; Mancina RM
    Appl Clin Genet; 2019; 12():71-78. PubMed ID: 31213876
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased Aortic Valve Calcification in Familial Hypercholesterolemia: Prevalence, Extent, and Associated Risk Factors.
    Ten Kate GR; Bos S; Dedic A; Neefjes LA; Kurata A; Langendonk JG; Liem A; Moelker A; Krestin GP; de Feyter PJ; Roeters van Lennep JE; Nieman K; Sijbrands EJ
    J Am Coll Cardiol; 2015 Dec; 66(24):2687-2695. PubMed ID: 26700830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation spectrum and polygenic score in German patients with familial hypercholesterolemia.
    Rieck L; Bardey F; Grenkowitz T; Bertram L; Helmuth J; Mischung C; Spranger J; Steinhagen-Thiessen E; Bobbert T; Kassner U; Demuth I
    Clin Genet; 2020 Nov; 98(5):457-467. PubMed ID: 32770674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Montreal-FH-SCORE Predicts Coronary Artery Calcium Score in Patients With Familial Hypercholesterolemia.
    Béland-Bonenfant S; Paquette M; Fantino M; Bourque L; Saint-Pierre N; Baass A; Bernard S
    CJC Open; 2021 Jan; 3(1):41-47. PubMed ID: 33458631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial hypercholesterolemia and cardiovascular disease in older individuals.
    Coutinho ER; Miname MH; Rocha VZ; Bittencourt MS; Jannes CE; Tada MT; Lima IR; Filho WS; Chacra AP; Pereira AC; Krieger JE; Santos RD
    Atherosclerosis; 2021 Feb; 318():32-37. PubMed ID: 33450476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of the genetic risk score to identify phenocopies in families with familial hypercholesterolemia?
    Ghaleb Y; Elbitar S; El Khoury P; Bruckert E; Carreau V; Carrié A; Moulin P; Di-Filippo M; Charriere S; Iliozer H; Farnier M; Luc G; Rabès JP; Boileau C; Abifadel M; Varret M
    Eur J Hum Genet; 2018 Apr; 26(4):570-578. PubMed ID: 29374275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
    Futema M; Bourbon M; Williams M; Humphries SE
    Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spectrum of low-density lipoprotein receptor (LDLR) mutations in a cohort of Sri Lankan patients with familial hypercholesterolemia - a preliminary report.
    Paththinige CS; Rajapakse JRDK; Constantine GR; Sem KP; Singaraja RR; Jayasekara RW; Dissanayake VHW
    Lipids Health Dis; 2018 May; 17(1):100. PubMed ID: 29720182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis.
    Al Rifai M; Yao J; Guo X; Post WS; Malik S; Blumenthal RS; Ballantyne CM; Budoff M; Taylor KD; Lin HJ; Rich SS; Hajek C; Greenland P; Rotter JI; Virani SS
    Prog Cardiovasc Dis; 2022; 74():19-27. PubMed ID: 35952728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rare and Deleterious Mutations in ABCG5/ABCG8 Genes Contribute to Mimicking and Worsening of Familial Hypercholesterolemia Phenotype.
    Tada H; Okada H; Nomura A; Yashiro S; Nohara A; Ishigaki Y; Takamura M; Kawashiri MA
    Circ J; 2019 Aug; 83(9):1917-1924. PubMed ID: 31327807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.